Sign In
Buy SOPH
$5.67
-0.0900 (-1.56%)
At Close: Jul 31, 2026
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
06:51am, Wednesday, 07'th Feb 2024
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland and MADRID , Feb. 7, 2024 /PRNewswire/ -- SOPHi
SOPHiA GENETICS Supports Genetic Testing in Brazil
10:50am, Thursday, 25'th Jan 2024
The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities BOSTON and ROLLE, Switzerland , Jan. 25, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SO
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
03:00pm, Thursday, 18'th Jan 2024
RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON and ROLLE, Switzerland , Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India
11:00pm, Sunday, 14'th Jan 2024
SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized can
SOPHiA GENETICS SA (SOPH) Q3 2023 Earnings Call Transcript
04:22pm, Saturday, 11'th Nov 2023
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q3 2023 Results Conference Call November 7, 2023 8:00 AM ET Company Participants Katherine Bailon - Head, IR Dr. Jurgi Camblong - Co-Founder and CEO Ross Muken - CFO
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023
05:50am, Tuesday, 24'th Oct 2023
BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will rele
SOPHiA GENETICS SA (SOPH) Q2 2023 Earnings Call Transcript
12:24pm, Saturday, 12'th Aug 2023
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Katherine Bailon - Head, Investor Relations Dr. Jurgi Camblong - Co-Founder and CEO Ro
SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Misses Revenue Estimates
09:55am, Tuesday, 08'th Aug 2023
SOPHiA GENETICS SA (SOPH) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.39 per share a year ago.
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2023 on August 8, 2023
07:35am, Tuesday, 25'th Jul 2023
BOSTON and ROLLE, Switzerland , July 25, 2023 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financia
SOPHiA GENETICS SA (SOPH) Q1 2023 Earnings Call Transcript
05:34am, Saturday, 13'th May 2023
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q1 2023 Earnings Conference Call May 9, 2023 8:00 AM ET Company Participants Katherine Bailon - Vice President of Investor Relations Jurgi Camblong - Co-Founder and C
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023
07:11am, Tuesday, 25'th Apr 2023
BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financi
SOPHiA GENETICS SA (SOPH) Surges 13.0%: Is This an Indication of Further Gains?
09:58am, Friday, 17'th Mar 2023
SOPHiA GENETICS SA (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near te
SOPHiA GENETICS SA (SOPH) Just Flashed Golden Cross Signal: Do You Buy?
11:28am, Thursday, 16'th Mar 2023
Is it a good or bad thing when a stock experiences a golden cross technical event?
SOPHiA GENETICS SA (SOPH) Q4 2022 Earnings Call Transcript
02:05pm, Tuesday, 07'th Mar 2023
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q4 2022 Results Earnings Conference Call March 7, 2023 8:00 AM ET Company Participants Katherine Bailon - Vice President, Investor Relations Jurgi Camblong - Founder
SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates
09:47am, Tuesday, 07'th Mar 2023
SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of 35.29% and 3.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
